Our team was assembled in 2005 to provide unbiased, scientifically-sound treatment options to patients with degenerative diseases. The organization arose from the unmet need to provide stem cell therapies that have been shown by others to meet the bar of safety in Phase I trials, but are not yet widely available because efficacy has not been proven.
Neil Riordan, PA, PhD
Our science originates from an American biotechnology company founded by Neil Riordan, PhD who together with leading Universities has published numerous papers in peer reviewed medical journals and has 17 families of patent applications.
Our medicine is founded on clinical use of stem cells. Since opening our doors in 2006, we have performed over 25,000 procedures. We routinely interact with colleagues in the USA and internationally who are using stem cells as part of clinical trials in order to incorporate the most recent advancements into patient care.
At the Stem Cell Institute, our mission is to be at the forefront of research of new treatment protocols for chronic diseases using adult stem cells, always according to the highest international bioethics standards, and offering, with transparency, honesty and human quality, treatments developed to improve the condition of our patients.
The characteristics of our organization which distinguish us from other stem cell treatment centers: